Novozymes A/S (NVZMY) Stock Price, News & Analysis

Company Overview

Novozymes A/S is a global biotechnology company specializing in the development and production of industrial enzymes and microorganisms. The company’s product portfolio includes a broad range of enzyme solutions for industries such as household care, food and beverage, agriculture, bioenergy and technical applications. By harnessing the catalytic power of proteins and the functional traits of microbes, Novozymes aims to replace traditional chemical processes with more sustainable, efficient and environmentally friendly alternatives.

The company’s enzymes are used to improve the performance and sustainability of everyday products. In household and laundry detergents, Novozymes’ enzymes enhance stain removal at lower temperatures and reduce energy consumption. In the food and beverage sector, its microbial and enzymatic technologies are applied to optimize processes such as baking, brewing and juice production, improving yield and consistency. In agriculture, the company offers biofertilizers and biostimulants designed to boost crop health and soil quality while reducing reliance on synthetic inputs.

Novozymes was established in 2000 as a spin-out from Denmark’s Novo Nordisk A/S, with headquarters in Bagsværd, Denmark. Since its inception, the company has expanded its reach to more than 130 countries, supported by a global network of R&D centers, production sites and sales offices. Continuous investment in research and innovation has enabled Novozymes to maintain a leadership position in enzyme and microbe technologies, collaborating with partners across the pharmaceutical, chemical and agricultural sectors to address evolving market needs.

Underpinning Novozymes’ strategy is a commitment to sustainability and circular bioeconomy principles. The company’s solutions are designed to reduce waste, energy use and greenhouse gas emissions, helping customers meet environmental targets and regulatory requirements. Through partnerships with industry leaders and ongoing development of next-generation biotechnologies, Novozymes continues to push the boundaries of industrial biology and support the global transition to cleaner, more efficient processes.

Key Stats

• Today's Range: $58.63 to $59.93
• 50-Day Range: $59.43 to $70.03
• 52-Week Range: $53.95 to $75.99
• Volume: 36,575 shs
• Average Volume: 40,627 shs
• Market Capitalization: $27.83 billion
• P/E Ratio: 37.61
• Dividend Yield: 0.62%
• Price Target: N/A
• Consensus Rating: Hold

Novozymes A/S Stock Analysis - MarketRank™

Novozymes A/S scored higher than 34% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Novozymes A/S.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 17.58%

Earnings Growth

Earnings for Novozymes A/S are expected to grow by 17.58% in the coming year, from $1.82 to $2.14 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Novozymes A/S is 37.61, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 280.42.

Price to Earnings Ratio vs. Sector

The P/E ratio of Novozymes A/S is 37.61, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 161.42.

Price to Earnings Growth Ratio

Novozymes A/S has a PEG Ratio of 1.18. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Novozymes A/S has a P/B Ratio of 2.30. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.01% of the float of Novozymes A/S has been sold short.

Short Interest Ratio / Days to Cover

Novozymes A/S has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Novozymes A/S has recently increased by 1,180.49%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Novozymes A/S has a dividend yield of 0.62%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Novozymes A/S does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Novozymes A/S is 23.42%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Novozymes A/S will have a dividend payout ratio of 17.29% next year. This indicates that Novozymes A/S will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.01% of the float of Novozymes A/S has been sold short.

Short Interest Ratio / Days to Cover

Novozymes A/S has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Novozymes A/S has recently increased by 1,180.49%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

MarketBeat Follows

1 people have added Novozymes A/S to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Novozymes A/S insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 0.03% of the stock of Novozymes A/S is held by institutions.

NVZMY Stock Analysis - Frequently Asked Questions

How have NVZMY shares performed this year?

Novozymes A/S's stock was trading at $56.5399 at the beginning of the year. Since then, NVZMY stock has increased by 5.1% and is now trading at $59.43.

How were Novozymes A/S's earnings last quarter?

Novozymes A/S (OTCMKTS:NVZMY) released its quarterly earnings results on Wednesday, January, 31st. The biotechnology company reported $0.36 earnings per share for the quarter, missing the consensus estimate of $0.47 by $0.11. The biotechnology company had revenue of $664.46 million for the quarter.

Does Novozymes A/S have any subsidiaries?

Novozymes A/S subsidiaries include PrecisionBiotics Group Limited, OrganoBalance GmbH, Pacific Vet Group-USA, Allopartis, TJ Technologies, Iogen Bio-Products, Natural Industries, and others.

How do I buy shares of Novozymes A/S?

Shares of NVZMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 1/31/2024
• Ex-Dividend for 9/11 Dividend: 9/02/2025
• Record date for 9/11 Dividend: 9/03/2025
• Dividend Payable: 9/11/2025
• Today: 9/26/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Basic Materials
• Industry: CHEM - SPECIALTY
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:NVZMY
• Previous Symbol: OTC:NVZMY
• CIK: 1131345
• Web: www.novozymes.com
• Phone: (454) 446-0000
• Fax: 45-4446-9999
• Employees: 10,582
• Year Founded: 2000

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 37.61
• Forward P/E Ratio: 32.65
• P/E Growth: 1.18
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.28
• Current Ratio: 1.75
• Quick Ratio: 1.07

Sales & Book Value

• Annual Sales: $4.15 billion
• Price / Sales: 6.71
• Cash Flow: $1.83 per share
• Price / Cash Flow: 32.43
• Book Value: $25.82 per share
• Price / Book: 2.30

Miscellaneous

• Outstanding Shares: 468,300,000
• Free Float: N/A
• Market Cap: $27.83 billion
• Optionable: Not Optionable
• Beta: 0.93